We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 426

Appeal of a finding of non-infringement of a U.S. Patent dismissed
  • Borden Ladner Gervais LLP
  • Canada
  • May 31 2017

The Ontario Court of Appeal dismissed an appeal of the Trial Judge's decision finding that the Respondent had not infringed the Appellant's patent in


Apotex's claims against current and former Ministers and civil servants working at the Ministry of Health is not struck for a lack of jurisdiction
  • Borden Ladner Gervais LLP
  • Canada
  • May 31 2017

The Federal Court has refused to strike a claim brought by Apotex against current and former ministers and civil servants working at the Ministry of


Defendant satisfied the two threshold factors for the right to examine the assignors
  • Borden Ladner Gervais LLP
  • Canada
  • May 31 2017

The Court dismissed an application to strike three appointments to examine for discovery. The underlying action concerns a claim for negligence


Court dismisses motion for Confidentiality Order
  • Borden Ladner Gervais LLP
  • Canada
  • May 18 2017

The Court dismissed Teva's motion for a confidentiality order. The underlying proceeding is an action by Teva to recover from Janssen and others


Reasonable Royalty and Accounting of Profits Determinations Made
  • Borden Ladner Gervais LLP
  • Canada
  • May 10 2017

In a previous decision, which was affirmed, the Court found that Dow's patent was valid and infringed by Nova. Once a finding of liability was made


Court Refuses Motion to Amend Brought After the Commencement of the Quantification Trial
  • Borden Ladner Gervais LLP
  • Canada
  • May 10 2017

This decision concerned the quantification phase following the liability determination, which found AstraZeneca's patent valid and infringed. Apotex


Findings Made in Section 8 Case to Allow Determination of Quantum of Damages
  • Borden Ladner Gervais LLP
  • Canada
  • May 10 2017

In this case, Teva is seeking compensation pursuant to s. 8 of the NOC Regulations for having been prevented from coming to market with its generic


Federal Court Holds That a Request to Find a Dead Patent Application in Good Standing Must Fail
  • Borden Ladner Gervais LLP
  • Canada
  • May 10 2017

The Federal Court has refused to declare that an application is in good standing after the applicants or their agents failed to reply to a requisition


Court of Appeal Dismisses Appeal for Different Reasons and Provides Review of the Obvious to Try Test
  • Borden Ladner Gervais LLP
  • Canada
  • April 19 2017

The Court of Appeal dismissed Bristol-Myers Squibb's appeal from the Trial Judge's decision refusing its application for a writ of prohibition on the


Court of Appeal Grants Appeal as it Relates to Duty to Mitigate
  • Borden Ladner Gervais LLP
  • Canada
  • April 19 2017

In this decision, the Court of Appeal was considering an appeal by Apotex of various findings of the Court relating to its action seeking damages from